Biotech: Pressemitteilungen - Kategorie - Seite 166

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Critical Outcome Technologies Inc. Announces Drug Discovery Agreement With Multinational Pharmaceutical Company

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwire) -- 12/06/12 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has entered into a drug discovery agreement with a multinational p ...

Emerging World Pharma Inc. Strategic Partner African Global Pharma GH Receives Ghana Food and Drug Board Packaging and Insert Approvals for Paracetamol Tablets

SUNYANI, GHANA: SUNYANI, GHANA -- (Marketwire) -- 12/06/12 -- Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) has received approvals of ...

Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwire) -- 12/05/12 -- (NASDAQ: PRAN) (ASX: PBT) today announced that leading scientists discussing the Metal Hypothesis at the New York Academy of Science on November 2 ...

ProMetic Achieves $1.0 Million Milestone With Hematech

LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwire) -- 12/05/12 -- ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic" or the "Corporation") announced today the achievement of the first milestone relat ...

Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform

BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 12/05/12 -- today announced that it has signed an option with Johns Hopkins University (JHU) for an exclusive license to develop and commercialize small molecule D-A ...

Sanguine Enters Letter of Intent

ATLANTA, GA: ATLANTA, GA -- (Marketwire) -- 12/05/12 -- Sanguine Corporation (OTCBB: SGUI), an innovator in perfluorocarbon ("PFC") based therapies, is pleased to announce that it has entered into a Let ...

Peregrine Pharmaceuticals Announces Significant Progress in Advancing Its Cotara Program Into a Pivotal Phase III Trial

TUSTIN, CA: Agreement Reached With FDA on Pivotal Trial Design for Its Novel Targeted Therapy Cotara for the Treatment of Recurrent Brain Cancer; Agreement Allows for Phase III Trial Planning While Advancing Part ...

Pharma-Bio Industry Expects to Wrap Up $12.6 Billion in 2012 North American Capital/MRO Investments, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwire) -- 12/05/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Before the doors close on 2012, the North American is on track to wrap up ...

Theravance Announces Initiation of Phase 2 Study With TD-9855 for the Treatment of Fibromyalgia

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 12/04/12 -- Theravance, Inc. (NASDAQ: THRX) announced today the initiation of a fibromyalgia Phase 2 study with TD-9855, the lead compound in Theravance ...

Leading Biotech Company Selects Dataflow Manager(TM) for Multiple Clinical Programs

CAMBRIDGE, MA: Implemented as an Enterprise Solution to Support Multiple Trial Outsourcing Models ...

Stellar Biotechnologies Files U.S. Patent Application for KLH Manufacturing Innovations

PORT HUENEME, CA: PORT HUENEME, CA -- (Marketwire) -- 12/04/12 -- (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) (FRANKFURT: RBT), the world leader in sustainable manufacture of GMP-grade Keyhole Limpet Hemocyanin (KLH), toda ...

Lorus Therapeutics Announces Positive Anticancer Data for IL-17E at AACR Tumor Immunology Conference

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 12/04/12 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...

Thallion Obtains Conditional Approval to List on the TSX-V and Concurrently Applies to Voluntarily Delist From the TSX

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwire) -- 12/04/12 -- Thallion Pharmaceuticals Inc. (TSX: TLN) ("Thallion") today announced that it has obtained conditional approval to list its common shares on ...

Marina Biotech Receives Key Patent Issuance From the USPTO for Its Unlocked Nucleobase Analog (UNA) Chemistry

BOTHELL, WA: Patent Broadly Covers RNA-Based Oligonucleotide Therapeutics Containing a UNA ...

Peregrine to Report Second Quarter Fiscal Year 2013 Financial Results After Market Close on December 10, 2012

TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 12/03/12 -- Peregrine Pharmaceuticals (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment ...

KineMatik and Blaze Systems Announce Strategic Alliance

CHICAGO, IL and NEWARK, DE: KineMatik Develops LinkLab, Available on the eNovator Platform, to Deliver Seamless Integration With Other Laboratory Informatics Systems Utilizing BlazeLink From Blaze Systems; LinkLab, Embedded Into ...


Seite 166 von 255:  « ..  165 166 167  168  169  170  171  172  173  174  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z